| 101 |
|
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants/
|
Freudenberger, T. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 102 |
|
A stand-off between rhAPC and LPS in healthy human subjects/
|
Hawiger, J. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 103 |
|
A subset of t(11; 14) lymphoma with mantle cell features displays mutated IgV~H genes and includes patients with good prognosis, nonnodal disease/
|
Orchard, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 104 |
|
A tale of 2 (or more) tails: PECAM-1 regulation of GPIb-IX-V signaling/
|
Lopez, J. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 105 |
|
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y~1~1 receptor signaling/
|
Schnurr, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 106 |
|
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells/
|
Li, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 107 |
|
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System/
|
Jaroscak, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 108 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 109 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 110 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 111 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 112 |
|
Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization/
|
Lemoli, R. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 113 |
|
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study/
|
Baldus, C. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 114 |
|
Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase/
|
Pollet, I
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 115 |
|
B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs/
|
Kamio, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 116 |
|
Bcl2 phosphorylation: a tie between cell survival, growth, and ROS/
|
Agostinis, P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 117 |
|
Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS/
|
Deng, X
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 118 |
|
BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs)/
|
Chiorean, E. G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 119 |
|
Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels/
|
Gambacorti-Passerini, C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 120 |
|
beta~2-Microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells/
|
Xie, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|